Abstract:Introduction Diabetic nephropathy is the leading cause of endstage renal disease worldwide and a leading cause of morbidity and mortality in diabetic patient. There is growing evidence that abnormal lipid metabolism and renal accumulation of lipids play a role in the pathogenesis of diabetic nephropathy (1-3). Kidney biopsy and histological analysis is not ideal for longitudinal follow-up studies. Proton (H) magnetic resonance (MR) imaging offers several non-invasive methods to obtain separate fat and water images, allowing for obtaining the fat-to-water ratio in tissues and quantifying the fat content. Sbarbati et al. applied chemical shift imaging (CSI) to quantify lipid in the brown adipose tissue in vivo (4). MR measurements of fat contents in the liver, skeletal muscle, pancreas and heart in vivo have been studied (58). However, to our knowledge, this non-invasive approach has not yet been applied and investigated for measuring the lipid accumulation in kidney. The purpose of this study was to study the feasibility and accuracy of in vivo MR measurement of lipid accumulation in kidney using the diabetes (db/db) mouse model. Methods All animal experiments were approved by the institutional Committee on Animal Research. Fifteen-week-old C57BLKS/J db/db and wild type (WT) mice (n=10) with an average weight of 51.63 ± 1.89 g and 31.38 ± 1.44 g were used in this study. Phantoms were made according to the volume percentage of fat ranging from 0% to 100%. All MR experiments were carried out using a 7.0 T small animal magnetic resonance system (Bruker PharmaScan, Ettlingen, Germany). CSI were performed to measure lipid contents (LCs) in phantoms, kidneys of mice. The results were compared to known LCs in phantoms and to the reference standard from mice by kidney lipid (KL) chemical analysis. T1WI was performed to estimate adipose tissue distribution of visceral (VS) and subcutaneous (SC) of mice. Results CSI underestimated fat concentration when FC was in range of 50% to 100%. Full details about imaging phantoms were described in our previous study (5). In vivo, the averaged LCCSI of the renal cortex and medulla in db/db mice were 12.73±0.94% and 6.46±1.02%, respectively. In comparison, the averaged LCCSI of renal cortex and medulla in WT mice were 3.16±0.50% and 2.67±0.70%. Significant differences in kidney LC in renal cortex and renal medulla between the db/db mice and WT mice were observed using the data from CSI (P<0.01). Interestingly, the Kidney LC in renal medulla of db/db mice is low than that in the renal cortex (P<0.01), but no significant difference between the renal cortex and medulla was found in WT mice (P=0.068). The averaged KL in db/db mice calculated by the chemical analysis method was higher than that of WT mice with 9.22±1.44mg and 4.11±0.74mg, respectively. A strong correlation between the averaged KL measured by the chemical method and the LC calculated by the MR method (r=0.916, P=0.000) was observed. Visceral fat of the total amount of white adipose tissue in db/db mice was significantly higher than that of WT mice. In the kidney sections of db/db mice examined by the oil-red O staining, lipids were found accumulated in the glomeruli and proximal tubules of the renal cortex, but not in the WT mice.

Renal fat deposition measured on dixon-based MRI is significantly associated with early kidney damage in obesity

Renal ectopic lipid deposition in rats with early-stage diabetic nephropathy evaluated by the MR mDixon-Quant technique: association with the expression of SREBP-1 and PPARα in renal tissue

Renal Fat Fraction and Diffusion Tensor Imaging in Patients with Early-Stage Diabetic Nephropathy

MRI Assessment of Renal Lipid Deposition and Abnormal Oxygen Metabolism of Type 2 diabetes Mellitus Based on mDixon‐Quant

Renal Adiposity Confounds Quantitative Assessment Of Markers Of Renal Diffusion With Mri A Proposed Correction Method

Quantification of the renal sinus fat and exploration of its relationship with ectopic fat deposition in normal subjects using MRI fat fraction mapping

In vivo quantification of renal lipid in diabetic mice by magnetic resonance imaging

Sonographic Evaluation of Para- and Perirenal Fat Thickness is an Independent Predictor of Early Kidney Damage in Obese Patients

Quantification of ectopic fat storage in the liver and pancreas using six-point Dixon MRI and its association with insulin sensitivity and β-cell function in patients with central obesity

Quantification of Renal Lipid and Oxygenation in Diabetic Mice by Magnetic Resonance Imaging

Quantification of Organ Fat Deposits in Patients with Type 2 Diabetes Mellitus by Magnetic Resonance Imaging

Magnetic Resonance Imaging Assessment of Abdominal Ectopic Fat Deposition in Correlation With Cardiometabolic Risk Factors

Comprehensive assessment of distinct abdominal fat compartments beyond liver content in overweight/obese patients using MRI and ultrasound imaging

Obesity Is Associated with Fatty Liver and Fat Changes in the Kidneys in Humans as Assessed by MRI

Perirenal fat thickness is an independent predictor for metabolic syndrome in steatotic liver disease

Automated Measurement of Pancreatic Fat Deposition on Dixon MRI Using Nnu-Net

Body composition as a potential imaging biomarker for predicting the progression risk of chronic kidney disease

Perirenal Fat Thickness Is Significantly Associated With the Risk for Development of Chronic Kidney Disease in Patients With Diabetes

Fatty acid composition evaluation of abdominal adipose tissue using chemical shiftencoded MRI: Association with diabetes

The Relationship Between Body Fat Distribution and Renal Damage in Chinese with Obesity

Association between relative fat mass and kidney stones in American adults